[go: up one dir, main page]

NO982405D0 - 1-(1-2-disubstituert piperidinyl)-4-(kondensert imidazol)-piperidinderivater - Google Patents

1-(1-2-disubstituert piperidinyl)-4-(kondensert imidazol)-piperidinderivater

Info

Publication number
NO982405D0
NO982405D0 NO982405A NO982405A NO982405D0 NO 982405 D0 NO982405 D0 NO 982405D0 NO 982405 A NO982405 A NO 982405A NO 982405 A NO982405 A NO 982405A NO 982405 D0 NO982405 D0 NO 982405D0
Authority
NO
Norway
Prior art keywords
piperidine derivatives
condensed imidazole
disubstituted piperidinyl
disubstituted
piperidinyl
Prior art date
Application number
NO982405A
Other languages
English (en)
Other versions
NO310916B1 (no
NO982405L (no
Inventor
Frans Eduard Janssens
Joseph Elisabeth Leenaerts
Yves Emiel Maria Va Roosbroeck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO982405D0 publication Critical patent/NO982405D0/no
Publication of NO982405L publication Critical patent/NO982405L/no
Publication of NO310916B1 publication Critical patent/NO310916B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19982405A 1995-12-27 1998-05-27 1-(1-2-disubstituert piperidinyl)-4-(kondensert imidazol)- piperidinderivater NO310916B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95203652 1995-12-27
PCT/EP1996/005885 WO1997024356A1 (en) 1995-12-27 1996-12-20 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives

Publications (3)

Publication Number Publication Date
NO982405D0 true NO982405D0 (no) 1998-05-27
NO982405L NO982405L (no) 1998-08-19
NO310916B1 NO310916B1 (no) 2001-09-17

Family

ID=8221024

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982405A NO310916B1 (no) 1995-12-27 1998-05-27 1-(1-2-disubstituert piperidinyl)-4-(kondensert imidazol)- piperidinderivater

Country Status (29)

Country Link
US (1) US6251894B1 (no)
EP (1) EP0843679B1 (no)
JP (1) JP4097043B2 (no)
KR (1) KR100485147B1 (no)
CN (1) CN1066733C (no)
AR (2) AR005278A1 (no)
AT (1) ATE208392T1 (no)
AU (1) AU716071B2 (no)
BR (1) BR9612307A (no)
CA (1) CA2238817C (no)
CY (1) CY2271B1 (no)
CZ (1) CZ295861B6 (no)
DE (1) DE69616802T2 (no)
DK (1) DK0843679T3 (no)
EA (1) EA001374B1 (no)
ES (1) ES2167619T3 (no)
HU (1) HU229766B1 (no)
IL (2) IL124641A (no)
MY (1) MY117680A (no)
NO (1) NO310916B1 (no)
NZ (1) NZ325845A (no)
PL (1) PL183767B1 (no)
PT (1) PT843679E (no)
SI (1) SI0843679T1 (no)
SK (1) SK283540B6 (no)
TR (1) TR199801210T2 (no)
TW (1) TW382017B (no)
WO (1) WO1997024356A1 (no)
ZA (1) ZA9610889B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW527186B (en) * 1996-03-19 2003-04-11 Janssen Pharmaceutica Nv Fused imidazole derivatives as multidrug resistance modulators
US6544979B1 (en) 1997-09-18 2003-04-08 Janssen Pharmaceuticals, N.V. Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
BR9916371A (pt) * 1998-12-19 2001-09-18 Janssen Pharmaceutica Nv Composto de espiro anti-histamìnico
AU7788500A (en) * 1999-10-25 2001-05-08 Janssen Pharmaceutica N.V. Use of substance p antagonists for influencing the circadian timing system
ES2475240T3 (es) 2001-06-12 2014-07-10 Janssen Pharmaceutica Nv Derivados de imidazol tetrac�clicos sustituidos novedosos, procesos para su preparación, composiciones farmacéuticas que los comprenden y su uso como medicamento
US20030083345A1 (en) * 2001-07-10 2003-05-01 Torsten Hoffmann Method of treatment and/or prevention of brain, spinal or nerve injury
EP1832287B1 (en) * 2001-11-23 2009-02-25 Janssen Pharmaceutica, N.V. The use of histamine receptor antagonists for the reduction of intracranial pressure
US7030107B2 (en) 2001-12-10 2006-04-18 Kyorin Pharmaceutical.Co., Ltd. Fused bicyclic pyridine derivatives as tachykinin receptor antagonists
US20050085510A1 (en) * 2002-01-16 2005-04-21 Telefonaktiebolaget Lm Ericsson (Publ) Prucalopride-n-oxide
AU2003201885B2 (en) * 2002-01-18 2007-08-30 Kyorin Pharmaceutical Co., Ltd. Fused bicyclic pyrimidine derivatives
US7026309B2 (en) 2002-03-26 2006-04-11 Kyorin Pharmaceutical Co., Ltd. Fused bicyclic pyridine derivative as tachykinin receptor antagonist
ATE400568T1 (de) * 2002-12-23 2008-07-15 Janssen Pharmaceutica Nv Substituierte 4-(4-piperidin-yl-piperazin-1-yl)- azepan-derivate und ihre verwendung als tachykinin-antagonisten
JO2696B1 (en) 2002-12-23 2013-03-03 شركة جانسين فارماسوتيكا ان. في Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists
JO2676B1 (en) 2004-04-06 2012-06-17 جانسين فارماسوتيكا ان. في Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines
JO2525B1 (en) * 2004-04-08 2010-03-17 شركة جانسين فارماسوتيكا ان. في Derived 4-alkyl-and-4-canoelperidine derivatives and their use as anti-neroquin
AU2006222061B2 (en) 2005-03-03 2011-04-28 Janssen Pharmaceutica N.V. Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
DE602006016244D1 (de) 2005-03-08 2010-09-30 Janssen Pharmaceutica Nv Diazaspiro-ä4,4ü-nonanderivate als neurokinin-(nk1)-antagonisten
CA2700477A1 (en) * 2007-07-19 2009-01-22 Adelaide Research & Innovation Pty Ltd Method for reducing intracranial pressure
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
ES2672099T3 (es) 2011-07-04 2018-06-12 Irbm - Science Park S.P.A. Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal
CN111918647A (zh) 2018-02-26 2020-11-10 圣拉斐尔医院有限公司 用于治疗眼痛的nk-1拮抗剂
WO2021180885A1 (en) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329353A (en) 1980-10-22 1982-05-11 Janssen Pharmaceutica, N.V. 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
US5393753A (en) * 1990-10-10 1995-02-28 Schering Corporation Substituted imidazobenzazepines
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv 10-(4-piperidinyl- and piperidinylidene)-imidazo [1,2-a] (pyrrolo thieno or furano) [2,3] azepine derivatives their preparation and pharmaceutical compositions containing them and certain novel intermediates therefor
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
ATE198480T1 (de) * 1993-07-13 2001-01-15 Janssen Pharmaceutica Nv Antiallergische imidazoazepine
NZ289498A (en) 1994-07-15 1998-02-26 Meiji Seika Co Piperidinylpiperazine derivatives such as various piperidinylpiperazinylacetylphenoxy acetic acid derivatives, pharmaceutical compositions
NZ321575A (en) 1995-10-30 1999-05-28 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives

Also Published As

Publication number Publication date
CA2238817C (en) 2006-10-17
EA199800603A1 (ru) 1998-12-24
BR9612307A (pt) 1999-07-13
HUP9903948A2 (hu) 2000-03-28
TW382017B (en) 2000-02-11
SK83098A3 (en) 1999-01-11
AU1308697A (en) 1997-07-28
CY2271B1 (en) 2003-07-04
CZ186598A3 (cs) 1998-11-11
US6251894B1 (en) 2001-06-26
JP2000506503A (ja) 2000-05-30
DE69616802T2 (de) 2002-07-04
JP4097043B2 (ja) 2008-06-04
SK283540B6 (sk) 2003-09-11
NO310916B1 (no) 2001-09-17
AU716071B2 (en) 2000-02-17
ZA9610889B (en) 1998-06-23
NZ325845A (en) 1999-06-29
EP0843679A1 (en) 1998-05-27
AR051817A2 (es) 2007-02-14
DK0843679T3 (da) 2002-02-25
IL124642A0 (en) 1998-12-06
CN1206417A (zh) 1999-01-27
KR100485147B1 (ko) 2005-09-13
ES2167619T3 (es) 2002-05-16
EP0843679B1 (en) 2001-11-07
TR199801210T2 (xx) 1999-10-21
DE69616802D1 (de) 2001-12-13
AR005278A1 (es) 1999-04-28
PL183767B1 (pl) 2002-07-31
IL124641A0 (en) 1998-12-06
PL327136A1 (en) 1998-11-23
ATE208392T1 (de) 2001-11-15
CA2238817A1 (en) 1997-07-10
CN1066733C (zh) 2001-06-06
MY117680A (en) 2004-07-31
HK1011206A1 (en) 1999-07-09
HUP9903948A3 (hu) 2000-04-28
HU229766B1 (hu) 2014-06-30
WO1997024356A1 (en) 1997-07-10
NO982405L (no) 1998-08-19
IL124641A (en) 2001-11-25
IL124642A (en) 2002-08-14
EA001374B1 (ru) 2001-02-26
SI0843679T1 (en) 2002-06-30
PT843679E (pt) 2002-04-29
KR19990076715A (ko) 1999-10-15
CZ295861B6 (cs) 2005-11-16

Similar Documents

Publication Publication Date Title
NO982405L (no) 1-(1-2-disubstituert piperidinyl)-4-(kondensert imidazol)-piperidinderivater
BR9611184A (pt) Derivados de 1-(1,2-Piperidinil dissubstituído)-4-piperazina substituída
DE69606721D1 (de) 1-(5-isochinolinsulfonyl)homopiperazin hydrochlorid
PT1123287E (pt) 1-(piridil substituido)-1,2,4-triazoles insecticidas
FI971234L (fi) Imidatsolijohdannainen
NO20015070D0 (no) Paroksetin-hydroklorid-anhydrat
MX9906600A (es) 4-(3-heterociclil-1-benzoil)pirazoles
FI955184L (fi) Bentsyylipiperidiinijohdannaiset
NO991563D0 (no) N-substituerte azaheterosykliske forbindelser
TR199501561A2 (tr) Imidazol türevleri.
BR9606815A (pt) Derivados de piperidina 4-(1H-indolil-1-il)-1-substituídos antipsicóticos
ID15912A (id) Turunan-turunan 1-(1,2-piperidinil yang didwisubstitusi)-4-(imidazol yang dilebur)-piperidin
ATE240320T1 (de) N-substituierte azaheterocyclische verbindungen
FI955916L (fi) N-((1-(4-(4-fluorifenoksi)butyyli)-4-piperidinyyli)-N-metyyliamino)-2-bentsotiatsololeja luokan III rytmihäiriölääkkeinä
FI915056A7 (fi) Substituoidut 1-(alkoksi-iminoalkyyli)imidatsoli-johdannaiset
NO963291L (no) Polymorfene B og C av 1-[2,4-diklor--[(7-klorbenzo[bÅtien-3-yl)metoksyÅfenetylÅimidazol mononitrat
DE59602428D1 (de) Stangenbohrlehre
FI955523A7 (fi) 1-(2-bentsimidatsolyyli)-1,5-diatsasyklo-oksataaniyhdisteet
FI960615A7 (fi) 1-(2-(substituoitu-vinyyli))-5H-2,3-bentsodiatsepiinijohdannaiset
KR970046366U (ko) 탄탈콘덴서 제작용 화성치구의 구조
ZA9610894B (en) 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives.
KR970025526U (ko) 칩 콘덴서

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees